The Ukrainian Times
Scientists of the Institute of Sorption and Problems of Endoecology (ISPE) under the National Academy of Sciences of Ukraine developed the new generation carbonic hemosorbent Karbon. Thanks to original scientific and technological solutions, Karbon enables the efficient removal of not only small molecules from the blood during hemosorption, but also molecular compounds.
The results of comparative clinical trials showed that Karbon has a more marked sorption capacity and other superior qualities than commercial carbonic
hemosorbents within the Commonwealth of Independent States.
Karbon is designed for the purification of blood in the cases of a liver coma, poisoning by various toxins, acute and chronic kidney insufficiency. It is the therapeutic substance, which is efficacious against toxicoses caused by tissue inflammation and breakdown, as well as against peritonitis, pancreatitis, sepsis and burns in particular.
The ISPE, together with the Byelorussian Medical University and the Minsk-based firm Pharmavit, have implemented a comprehensive innovation project that resulted in the organization of production of sorption columns with Karbon in Byelorussia. These columns will be used for purifying blood.
In addition, the project provides for the organization of their production at a pharmaceutical company in Ukraine. As expected, annual output and sales volume will amount to 25,000 sorption columns at the first stage scheduled for 2016-2017 and reach 50,000 columns at the second stage starting in 2018.
No comments:
Post a Comment